These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16621538)

  • 1. Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.
    Ablordeppey SY; Lyles-Eggleston M; Bricker B; Zhang W; Zhu X; Goodman C; Roth BL
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3219-23. PubMed ID: 16621538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.
    Peprah K; Zhu XY; Eyunni SV; Etukala JR; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2012 Mar; 20(5):1671-8. PubMed ID: 22336245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species.
    Lyles-Eggleston M; Altundas R; Xia J; Sikazwe DM; Fan P; Yang Q; Li S; Zhang W; Zhu X; Schmidt AW; Vanase-Frawley M; Shrihkande A; Villalobos A; Borne RF; Ablordeppey SY
    J Med Chem; 2004 Jan; 47(3):497-508. PubMed ID: 14736232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.
    Chakrabarty R; Rao J; Anand A; Roy AD; Roy R; Shankar G; Dua PR; Saxena AK
    Bioorg Med Chem; 2007 Dec; 15(23):7361-7. PubMed ID: 17869521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.
    Ablordeppey SY; Altundas R; Bricker B; Zhu XY; Kumar EV; Jackson T; Khan A; Roth BL
    Bioorg Med Chem; 2008 Aug; 16(15):7291-301. PubMed ID: 18595716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYA 013 analogs as moderately selective sigma-2 (σ
    Al-Ghanim L; Zhu XY; Asong G; Ablordeppey SY
    Bioorg Med Chem; 2019 Jun; 27(12):2421-2426. PubMed ID: 30737135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evaluation of the tropane analogs of haloperidol.
    Sampson D; Bricker B; Zhu XY; Peprah K; Lamango NS; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4294-7. PubMed ID: 25070422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
    Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belaperidone (Knoll AG).
    Tricklebank MD
    IDrugs; 2000 Feb; 3(2):228-31. PubMed ID: 16107943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cataleptic effects of optically active dihydrohaloperidols and dihydrobromoperidols.
    Takeshita M; Miura M; Hongo T; Ohkubo T; Sugawara K; Kosaka K; Takeshita Y; Araki T; Oshima Y
    Chirality; 1997; 9(5-6):443-5. PubMed ID: 9329176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction.
    Kolasa T; Matulenko MA; Hakeem AA; Patel MV; Mortell K; Bhatia P; Henry R; Nakane M; Hsieh GC; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino B; El Kouhen O; Marsh KC; Wetter JM; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2006 Aug; 49(17):5093-109. PubMed ID: 16913699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
    Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
    Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A
    J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
    Bannwart LM; Carter DS; Cai HY; Choy JC; Greenhouse R; Jaime-Figueroa S; Iyer PS; Lin CJ; Lee EK; Lucas MC; Lynch SM; Madera AM; Moore A; Ozboya K; Raptova L; Roetz R; Schoenfeld RC; Stein KA; Steiner S; Villa M; Weikert RJ; Zhai Y
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6062-6. PubMed ID: 18954985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sila-haloperidol, a silicon analogue of the dopamine (D2) receptor antagonist haloperidol: synthesis, pharmacological properties, and metabolic fate.
    Tacke R; Popp F; Müller B; Theis B; Burschka C; Hamacher A; Kassack MU; Schepmann D; Wünsch B; Jurva U; Wellner E
    ChemMedChem; 2008 Jan; 3(1):152-64. PubMed ID: 18022977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.